Healthy Skepticism Library item: 10147

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Moynihan R.
Consumers fight to halt move towards direct to consumer advertising in Europe
BMJ 2007 May 19; 334:(7602):1025
http://www.bmj.com/cgi/content/full/334/7602/1025

Abstract:

An international alliance of consumer and other groups has attacked the European Commission, accusing it of supporting the drug industry’s push for direct to consumer advertising in Europe.

US-style advertising of prescription drugs aimed directly at consumers is currently prohibited in Europe, and attempts to overturn the ban were firmly rejected by the European parliament in 2002 (BMJ 2002;325:990 doi: 10.1136/bmj.325.7371.990/a).

However, the drug industry and elements within the European Commission are pushing to change the rules so that drug companies can provide more information to patients across Europe, a move that critics argue is an underhand way of introducing advertising.

Taking a position in support of loosening the rules, a European Commission draft report that is currently out for public discussion states, “The focus should be on the availability and quality of information, and not its source,” and it says that “the pharmaceutical industry has the potential . . .